Skip to main content
Log in

Orphan drug pricing and reimbursement policies lacking in EU

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Sarnola K, et al. Policies and availability of orphan medicines in outpatient care in 24 European countries. European Journal of Clinical Pharmacology : 9 Apr 2018. Available from: URL: http://doi.org/10.1007/s00228-018-2457-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Orphan drug pricing and reimbursement policies lacking in EU. PharmacoEcon Outcomes News 803, 18 (2018). https://doi.org/10.1007/s40274-018-4945-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4945-8

Navigation